Cbl-b-IN-1 (example 519 presented in the referenced in patent WO2019148005A1) is a novel and potent Cbl-b inhibitor, with an IC50<100 nM.

References:INHIBITORS OF CBL-B AND METHODS OF USE THEREOF. WO/2019/148005A1.

纯度：≥98%

CAS：2368841-84-1